Highlights Star Combo Pharma Limited

Equities

S66

AU0000004798

Market Closed - Australian S.E. Other stock markets 20:16:30 2024-06-04 EDT			5-day change	1st Jan Change
0.11 ^AUD	-8.33%		-8.33%	-24.14%

02-27	Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-26	CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29	CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI
An unknown buyer acquired 49% stake in Austoyou Group Pty Ltd and Koala Mall Pty Ltd from Star Combo Pharma Limited.	23-02-23	CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-23	CI
Star Combo Pharma Issues Shares to Vietnamese Distributor	22-07-05	MT
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-23	CI
Star Combo Pharma Limited Announces Supplementary Announcement on New Contract	21-11-08	CI
Star Combo Pharma Secures Nearly $4 Million Order for Bulk Capsules	21-11-04	MT
Star Combo Pharma Limited Receives $5.0 Million Order	21-11-03	CI
Star Combo Signs 12-Month Exclusive Distribution Agreement with Happy Co. Ltd for Widespread Sales and Distribution of its Proprietary Health Supplement Product Line, Costar Across Vietnam	21-10-10	CI
Star Combo Pharma : Secures Approval for New Research and Development Facility	21-09-06	MT
Star Combo Pharma Limited Announces Development Application Approval Receives for R&D Facilities At Smithfield	21-09-05	CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-23	CI
Star Combo Pharma Limited Continues to Progress its Contract Manufacturing Expansion Strategy	20-11-02	CI
Star Combo Pharma Limited Announces the Expansion of Its Manufacturing Capabilities At Its Wholly-Owned Tga-Licensed Nutraceutical Manufacturing Site	20-08-31	CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-25	CI
Star Combo Pharma Limited Completes the Purchase of Land Located At 165 Woodpark Road, Smithfield, New South Wales	20-08-06	CI
Star Combo Pharma Limited Expands Capacity - Milk Powder Blend and Pack Facility	20-08-03	CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Star Combo Pharma Limited

Equities

S66

AU0000004798

Highlights

Filters